Cadrenal Therapeutics Registers Additional 196,773 Shares for Equity Incentive Plan

Filing content

Cadrenal Therapeutics filed an S-8 registration statement to register an additional 196,773 shares of common stock issuable under its 2022 Successor Equity Incentive Plan pursuant to an evergreen provision.